Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tennant

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Biomolecular NMR|May 11, 2000
Assignment of 1H, 13C and 15N resonances of the I-domain of human leukocyte function associated antigen-1R W Kriwacki, G B Legge, U Hommel, et al.
Patient Education and Counseling|March 14, 2024
Communicating medical device recalls: A rapid review of the literatureBethany L Tennant, Casey Langer Tesfaye, Melanie C Chansky, et al.
Journal of Biomolecular NMR|September 8, 1998
Chemical shift as a probe of molecular interfaces: NMR studies of DNA binding by the three amino-terminal zinc finger domains from transcription factor IIIAM P Foster, D S Wuttke, K R Clemens, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|March 1, 1995
Forward light scatter at one month after photorefractive keratectomyJ M Harrison, T B Tennant, M C Gwin, et al.
Medicine and Science in Sports and Exercise|May 17, 2019
Physical Activity Promotion: Highlights from the 2018 Physical Activity Guidelines Advisory Committee Systematic ReviewAbby C King, Melicia C Whitt-Glover, David X Marquez, et al.
Breast (Edinburgh, Scotland)|October 3, 2008
Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected casesS L Tennant, A Evans, L J Hamilton, et al.
The British Journal of Radiology|November 13, 2015
Accuracy of GE digital breast tomosynthesis vs supplementary mammographic views for diagnosis of screen-detected soft-tissue breast lesionsEleanor J Cornford, Anne E Turnbull, Jonathan J James, et al.
Journal for Immunotherapy of Cancer|June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanomaYousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Biomolecular NMR|May 11, 2000
Assignment of 1H, 13C and 15N resonances of the I-domain of human leukocyte function associated antigen-1R W Kriwacki, G B Legge, U Hommel, et al.
Patient Education and Counseling|March 14, 2024
Communicating medical device recalls: A rapid review of the literatureBethany L Tennant, Casey Langer Tesfaye, Melanie C Chansky, et al.
Journal of Biomolecular NMR|September 8, 1998
Chemical shift as a probe of molecular interfaces: NMR studies of DNA binding by the three amino-terminal zinc finger domains from transcription factor IIIAM P Foster, D S Wuttke, K R Clemens, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|March 1, 1995
Forward light scatter at one month after photorefractive keratectomyJ M Harrison, T B Tennant, M C Gwin, et al.
Medicine and Science in Sports and Exercise|May 17, 2019
Physical Activity Promotion: Highlights from the 2018 Physical Activity Guidelines Advisory Committee Systematic ReviewAbby C King, Melicia C Whitt-Glover, David X Marquez, et al.
Breast (Edinburgh, Scotland)|October 3, 2008
Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected casesS L Tennant, A Evans, L J Hamilton, et al.
The British Journal of Radiology|November 13, 2015
Accuracy of GE digital breast tomosynthesis vs supplementary mammographic views for diagnosis of screen-detected soft-tissue breast lesionsEleanor J Cornford, Anne E Turnbull, Jonathan J James, et al.
Journal for Immunotherapy of Cancer|June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanomaYousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Pageof 6